Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2021-07-30 00:00:00 ET · period of report 2021-07-29 · accession 0001209191-21-048919 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-30 | 2021-07-29 | BCYC | Kalowski Lee | Pres, CFO | M - OptEx | $1.63 | +12.5K | 12.5K | New | +$20.4K |
| DM | 2021-07-30 | 2021-07-29 | BCYC | Kalowski Lee | Pres, CFO | S - Sale+OE | $31.51 | -12.5K | 0 | -100% | -$393.8K |
| D | 2021-07-30 | 2021-07-29 | BCYC | Kalowski Lee | Pres, CFO | M - OptEx | $0.00 | -12.5K | 67.3K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-07-29 | M | A | 12,500 | $1.63 | 12,500 | D | — | — | (F2) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.39511 to GBP 1.00 as of July 29, 2021. |
| 2 | Common | Ordinary Shares | 2021-07-29 | S | D | 8,996 | $31.24 | 3,504 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.73 to $31.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5). |
| 3 | Common | Ordinary Shares | 2021-07-29 | S | D | 3,204 | $32.13 | 300 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.77 to $32.76 inclusive. |
| 4 | Common | Ordinary Shares | 2021-07-29 | S | D | 300 | $32.81 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.78 to $32.86 inclusive. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-07-29 | M | D | 12,500 | $0.00 | 67,274 | D | $1.63 · — to 2027-07-23 | 12,500 Ordinary Shares | (F2) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.39511 to GBP 1.00 as of July 29, 2021. (F6) 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. |